Brain Injuries Clinical Trial
— BSC-CI-NPCOfficial title:
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
NCT number | NCT04074486 |
Other study ID # | 55/60 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 2, 2019 |
Est. completion date | March 31, 2022 |
Verified date | June 2022 |
Source | BrainScope Company, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (ED) across the country, over an 18-month period (Phase 2, 12 months for Algorithm Development and Norming, and Phase 3, 6 months for Validation).
Status | Completed |
Enrollment | 1318 |
Est. completion date | March 31, 2022 |
Est. primary completion date | January 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 50 Years |
Eligibility | Inclusion Criteria: - Age =13 and <51 years old at time of enrollment; - No prior history of concussion or TBI in the last 6 months. For head injured subjects - Having sustained a traumatic closed head injury within 120 hours (5 days from time of injury at time of BrainScope assessment); - GCS 13-15 at time of BrainScope assessment. For non-concussed head-injured controls - Having sustained a traumatic closed head injury but returned to play or deemed non-concussed following sideline (on-field) evaluation within the same game and enrolled in the study within 120 hours (5 days) from said incident. - GCS 13-15 at time of BrainScope assessment. For matched controls and healthy volunteers • GCS 15 at time of BrainScope assessment. Exclusion Criteria: - Enrolled in any previous BrainScope clinical study; - Current CNS active prescription medications taken daily, except for medication being taken for the treatment of Attention Deficit Disorders (ADD/ADHD); medication for smoking cessation; or medications for anxiety taken PRN (as needed); - Forehead, scalp or skull abnormalities that prevents headset application for EEG data collection in injured/matched controls; - History of brain tumor, brain surgery or known neurological disease including, Parkinson's, MS, Alzheimer's, dementia, epilepsy; - History of TIA or Stroke within the last year; - Pregnant women; - Subjects who do not speak English (non-English speaking parents are allowed to consent so long as translation of the consent form in their native language is available); - Acute intoxication ; - Evidence of illicit drug abuse in the last year; - Active fever defined as greater than 100ºF or 37.78ºC at time of BrainScope assessment; - Subjects currently receiving dialysis or have end-stage renal disease; - Subjects requiring advanced airway management (i.e. mechanical ventilation); - Prisoners. For head injured subjects - Loss of consciousness = 20 minutes related to the concussion injury; - Evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (note: neuroimaging is not required for enrollment); - For current injury, hospital admission (other than the Observation Unit) ranging more than 24 hours due to either head injury or collateral injuries. For non-concussed head-injured controls - Loss of consciousness = 20 minutes related to the head impact; - Any focal neurological signs including aphasia, apraxia, diplopia, facial droop, dysarthria/slurred speech; - Any score >3 on a 7-point Likert scale (0=none, 6=severe) for the following symptoms at the time of BrainScope assessment (compared to how the subject normally feels): headache, dizziness, balance problems, neck pain, feeling slowed down; For matched controls and healthy volunteers - Any focal neurological signs including aphasia, apraxia, diplopia, facial droop, dysarthria/slurred speech; - Hospital admission (other than the Observation Unit) ranging more than 24 hours due to either head injury or collateral injuries in the past 6 months; - Any score >3 on a 7-point Likert scale (0=none, 6=severe) for the following symptoms at the time of BrainScope assessment (compared to how the subject normally feels): headache, dizziness, balance problems, neck pain, feeling slowed down. For healthy volunteers - Legally blind in one or both eyes; - History of eye surgery in the past year; - Any known eye disorders including age-related macular degeneration (AMD), glaucoma, lazy eye, diplopia, cataracts, etc. |
Country | Name | City | State |
---|---|---|---|
United States | Michigan State University | East Lansing | Michigan |
United States | INOVA Health System | Fairfax | Virginia |
United States | University of Arkansas | Fayetteville | Arkansas |
United States | University of Miami | Miami | Florida |
United States | University of Rochester Medical Center | Rochester | New York |
United States | University of Connecticut | Storrs | Connecticut |
Lead Sponsor | Collaborator |
---|---|
BrainScope Company, Inc. | United States Department of Defense |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity and Specificity of the multivariate and multimodal Concussion Index | Sensitivity and specificity of the expanded CI for assessment of the likelihood of concussion in subjects ages 13-50 who sustained a closed head injury. | 18 months for data acquisition | |
Secondary | Efficacy of use | The demonstration of efficacy of use of this biomarker of brain function impairment/concussion to assess readiness to return to normal activity | 18 months for data acquisition | |
Secondary | Identification of concussion subtypes | Validation of subtypes (at time of injury) with different clinical characterizations and outcome (e.g., rapid versus prolonged recovery). | 18 months for data acquisition |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05542108 -
Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants
|
N/A | |
Completed |
NCT03400904 -
Extubation Strategies in Neuro-Intensive Care Unit Patients and Associations With Outcome.
|
||
Completed |
NCT06073145 -
Transcranial Doppler Using Wearable Ultrasound Patch
|
||
Recruiting |
NCT03899532 -
Remote Ischemic Conditioning in Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT06010823 -
Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants
|
N/A | |
Not yet recruiting |
NCT05833568 -
Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness
|
N/A | |
Withdrawn |
NCT04288076 -
The Brain and Lung Interaction (BALI) Study
|
N/A | |
Not yet recruiting |
NCT02756585 -
Computed Tomography Perfusion in Patients With Severe Head Injury
|
N/A | |
Completed |
NCT03162484 -
Physical Activity and Chronic Acquired Brain Injury
|
N/A | |
Terminated |
NCT01430988 -
Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury
|
N/A | |
Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A | |
Completed |
NCT00975338 -
The LETS Study: A Longitudinal Evaluation of Transition Services
|
||
Completed |
NCT00878631 -
Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline
|
Phase 2/Phase 3 | |
Completed |
NCT03166722 -
Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition
|
N/A | |
Not yet recruiting |
NCT04478812 -
Tbit System Precision and Correlation of Different Blood Samples
|
N/A | |
Recruiting |
NCT05443542 -
VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI
|
N/A | |
Recruiting |
NCT05309005 -
Virtual Reality and Social Cognition After Acquired Brain Injury
|
||
Completed |
NCT02702635 -
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
|
N/A | |
Withdrawn |
NCT04247321 -
Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure
|
N/A | |
Not yet recruiting |
NCT04386525 -
Omega 3 and Ischemic Stroke; Fish Oil as an Option
|
Phase 4 |